These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 23532410)
61. Cyanobactins from Cyanobacteria: Current Genetic and Chemical State of Knowledge. Martins J; Vasconcelos V Mar Drugs; 2015 Nov; 13(11):6910-46. PubMed ID: 26580631 [TBL] [Abstract][Full Text] [Related]
62. Discovery of Cyanobacterial Natural Products Containing Fatty Acid Residues*. Figueiredo SAC; Preto M; Moreira G; Martins TP; Abt K; Melo A; Vasconcelos VM; Leão PN Angew Chem Int Ed Engl; 2021 Apr; 60(18):10064-10072. PubMed ID: 33599093 [TBL] [Abstract][Full Text] [Related]
63. Anti-lung cancer properties of cyanobacterial bioactive compounds. Baig MS; Rajpoot S; Ohishi T; Savai R; Seidel S; Kamennaya NA; Bezsonov EE; Orekhov AN; Mahajan P; Solanki K; Saqib U Arch Microbiol; 2022 Sep; 204(10):603. PubMed ID: 36063223 [TBL] [Abstract][Full Text] [Related]
64. Biological effects of tolytoxin (6-hydroxy-7-O-methyl-scytophycin b), a potent bioactive metabolite from cyanobacteria. Patterson GM; Carmeli S Arch Microbiol; 1992; 157(5):406-10. PubMed ID: 1510566 [TBL] [Abstract][Full Text] [Related]
65. Phycochemistry and bioactivity of cyanobacterial secondary metabolites. Srivastava R; Prajapati R; Kanda T; Yadav S; Singh N; Yadav S; Mishra R; Atri N Mol Biol Rep; 2022 Nov; 49(11):11149-11167. PubMed ID: 36161579 [TBL] [Abstract][Full Text] [Related]
66. Medicinal applications of perfluoroalkylated chain-containing compounds. Prchalová E; Štěpánek O; Smrček S; Kotora M Future Med Chem; 2014 Jun; 6(10):1201-29. PubMed ID: 25078138 [TBL] [Abstract][Full Text] [Related]
67. Novel method enabling a rapid vitality determination of cyanobacteria. Witthohn M; Schwarz A; Walther J; Strieth D; Ulber R; Muffler K Eng Life Sci; 2020 Dec; 20(12):580-584. PubMed ID: 33304231 [TBL] [Abstract][Full Text] [Related]
68. Can we use Nature's Structure-Activity-Relationships to Make Better Drugs? Kenakin T Drug Discov Today; 2019 Sep; 24(9):1701-1703. PubMed ID: 31419394 [No Abstract] [Full Text] [Related]
69. Optimizing Luminous Transmittance of a Three-Dimensional-Printed Fixed Bed Photobioreactor. Scherer K; Huwer A; Ulber R; Wahl M 3D Print Addit Manuf; 2024 Apr; 11(2):467-475. PubMed ID: 38689931 [TBL] [Abstract][Full Text] [Related]
70. Cytochrome P450s in algae: Bioactive natural product biosynthesis and light-driven bioproduction. Zheng S; Guo J; Cheng F; Gao Z; Du L; Meng C; Li S; Zhang X Acta Pharm Sin B; 2022 Jun; 12(6):2832-2844. PubMed ID: 35755277 [TBL] [Abstract][Full Text] [Related]
71. Cyanobacterial secondary metabolites towards improved commercial significance through multiomics approaches. Verma S; Thapa S; Siddiqui N; Chakdar H World J Microbiol Biotechnol; 2022 Apr; 38(6):100. PubMed ID: 35486205 [TBL] [Abstract][Full Text] [Related]
72. Mechanism of Action of Shenerjiangzhi Formulation on Hyperlipidemia Induced by Consumption of a High-Fat Diet in Rats Using Network Pharmacology and Analyses of the Gut Microbiota. Zhang S; Wang Y; Lu F; Mohammed SAD; Liu H; Ding S; Liu SM Front Pharmacol; 2022; 13():745074. PubMed ID: 35450051 [TBL] [Abstract][Full Text] [Related]
73. Inhibition of Filamentous Thermosensitive Mutant-Z Protein in Gurnani M; Rath P; Chauhan A; Ranjan A; Ghosh A; Lal R; Mukerjee N; Aljarba NH; Alkahtani S; Rajput VD; Sushkova S; Prazdnova EV; Minkina T; Jindal T Molecules; 2022 Mar; 27(6):. PubMed ID: 35335270 [TBL] [Abstract][Full Text] [Related]
74. Influence of wettability and surface design on the adhesion of terrestrial cyanobacteria to additive manufactured biocarriers. Scherer K; Soerjawinata W; Schaefer S; Kockler I; Ulber R; Lakatos M; Bröckel U; Kampeis P; Wahl M Bioprocess Biosyst Eng; 2022 May; 45(5):931-941. PubMed ID: 35235034 [TBL] [Abstract][Full Text] [Related]
75. Multi-product biorefinery from Arthrospira platensis biomass as feedstock for bioethanol and lactic acid production. Esquivel-Hernández DA; Pennacchio A; Torres-Acosta MA; Parra-Saldívar R; de Souza Vandenberghe LP; Faraco V Sci Rep; 2021 Sep; 11(1):19309. PubMed ID: 34588465 [TBL] [Abstract][Full Text] [Related]
76. Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications. Khalifa SAM; Shedid ES; Saied EM; Jassbi AR; Jamebozorgi FH; Rateb ME; Du M; Abdel-Daim MM; Kai GY; Al-Hammady MAM; Xiao J; Guo Z; El-Seedi HR Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33923369 [TBL] [Abstract][Full Text] [Related]
77. Diversity, Cyanotoxin Production, and Bioactivities of Cyanobacteria Isolated from Freshwaters of Greece. Gkelis S; Panou M; Konstantinou D; Apostolidis P; Kasampali A; Papadimitriou S; Kati D; Di Lorenzo GM; Ioakeim S; Zervou SK; Christophoridis C; Triantis TM; Kaloudis T; Hiskia A; Arsenakis M Toxins (Basel); 2019 Jul; 11(8):. PubMed ID: 31349572 [TBL] [Abstract][Full Text] [Related]